Literature DB >> 18983507

Phosphatidylethanolamine at the endothelial surface of aortic flow dividers.

Z Li, C W Wells, C T Esmon, M Zhao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18983507     DOI： 10.1111/j.1538-7836.2008.03193.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  8 in total

1.  Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin.

Authors:  Said Audi; Zhixin Li; Joseph Capacete; Yu Liu; Wei Fang; Laura G Shu; Ming Zhao
Journal:  Nucl Med Biol       Date:  2012-04-23       Impact factor: 2.408

Review 2.  Lantibiotics as probes for phosphatidylethanolamine.

Authors:  Ming Zhao
Journal:  Amino Acids       Date:  2009-11-22       Impact factor: 3.520

3.  Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.

Authors:  Zhonglin Liu; Brandon T Larsen; Lilach O Lerman; Brian D Gray; Christy Barber; Ahmad F Hedayat; Ming Zhao; Lars R Furenlid; Koon Y Pak; James M Woolfenden
Journal:  Nucl Med Biol       Date:  2016-05-19       Impact factor: 2.408

4.  Early endosome as a pathogenic target for antiphosphatidylethanolamine antibodies.

Authors:  Songwang Hou; Heike Fölsch; Ke Ke; Joan Cook Mills; Rosalind Ramsey-Goldman; Ming Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

5.  Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium.

Authors:  Jason H Stafford; Philip E Thorpe
Journal:  Neoplasia       Date:  2011-04       Impact factor: 5.715

Review 6.  Development of Duramycin-Based Molecular Probes for Cell Death Imaging.

Authors:  Dongjian Zhang; Meng Gao; Qiaomei Jin; Yicheng Ni; Huailiang Li; Cuihua Jiang; Jian Zhang
Journal:  Mol Imaging Biol       Date:  2022-02-10       Impact factor: 3.484

7.  Phosphatidylethanolamine at the luminal endothelial surface--implications for hemostasis and thrombotic autoimmunity.

Authors:  Clive W Wells; Paula E North; Suresh Kumar; Christine B Duris; John A McIntyre
Journal:  Clin Appl Thromb Hemost       Date:  2009-11-10       Impact factor: 2.389

8.  A single-step kit formulation for the (99m)Tc-labeling of HYNIC-Duramycin.

Authors:  Ming Zhao; Zhixin Li
Journal:  Nucl Med Biol       Date:  2012-08-02       Impact factor: 2.408
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.